CYP39A1
Basic information
Region (hg38): 6:46549580-46652830
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP39A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 21 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 19 | 5 | 0 |
Variants in CYP39A1
This is a list of pathogenic ClinVar variants found in the CYP39A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-46550416-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
6-46550418-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
6-46587087-A-G | not specified | Uncertain significance (Feb 26, 2024) | ||
6-46588126-A-G | not specified | Uncertain significance (Jun 10, 2024) | ||
6-46625421-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
6-46625429-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
6-46625433-C-G | not specified | Uncertain significance (Jul 06, 2021) | ||
6-46625457-C-T | not specified | Likely benign (May 28, 2024) | ||
6-46625474-T-A | not specified | Uncertain significance (Mar 17, 2023) | ||
6-46625485-G-A | not specified | Likely benign (Dec 17, 2023) | ||
6-46630968-C-A | not specified | Uncertain significance (Jan 19, 2024) | ||
6-46630970-G-A | not specified | Uncertain significance (Dec 06, 2023) | ||
6-46631010-T-C | not specified | Uncertain significance (May 09, 2022) | ||
6-46636408-G-C | Likely benign (Nov 01, 2022) | |||
6-46636438-T-C | not specified | Uncertain significance (Apr 23, 2024) | ||
6-46637839-A-T | not specified | Uncertain significance (Nov 17, 2022) | ||
6-46637926-A-G | not specified | Likely benign (Aug 02, 2023) | ||
6-46637931-A-C | not specified | Likely benign (Feb 17, 2024) | ||
6-46637944-A-C | not specified | Uncertain significance (Dec 16, 2022) | ||
6-46637947-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
6-46637950-T-C | not specified | Uncertain significance (Sep 27, 2021) | ||
6-46639581-T-C | not specified | Uncertain significance (Apr 19, 2024) | ||
6-46639644-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
6-46639654-T-C | not specified | Uncertain significance (Apr 13, 2022) | ||
6-46642175-C-A | not specified | Uncertain significance (Jan 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP39A1 | protein_coding | protein_coding | ENST00000275016 | 12 | 102983 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.87e-16 | 0.0111 | 125612 | 0 | 136 | 125748 | 0.000541 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0649 | 235 | 232 | 1.01 | 0.0000106 | 3077 |
Missense in Polyphen | 61 | 66.85 | 0.9125 | 893 | ||
Synonymous | -0.941 | 95 | 84.0 | 1.13 | 0.00000405 | 849 |
Loss of Function | 0.0977 | 24 | 24.5 | 0.979 | 0.00000112 | 328 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000277 | 0.000275 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000436 | 0.000435 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.000294 | 0.000290 |
Middle Eastern | 0.000436 | 0.000435 |
South Asian | 0.00262 | 0.00258 |
Other | 0.00101 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the bile acid metabolism. Has a preference for 24-hydroxycholesterol, and converts it into a 7-alpha- hydroxylated product. {ECO:0000269|PubMed:10748047}.;
- Pathway
- Primary bile acid biosynthesis - Homo sapiens (human);27-Hydroxylase Deficiency;Bile Acid Biosynthesis;Congenital Bile Acid Synthesis Defect Type II;Cerebrotendinous Xanthomatosis (CTX);Zellweger Syndrome;Familial Hypercholanemia (FHCA);Congenital Bile Acid Synthesis Defect Type III;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Endogenous sterols;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of steroids
(Consensus)
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- loftool
- 0.428
- rvis_EVS
- 2.18
- rvis_percentile_EVS
- 98.07
Haploinsufficiency Scores
- pHI
- 0.285
- hipred
- N
- hipred_score
- 0.219
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00228
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp39a1
- Phenotype
Gene ontology
- Biological process
- bile acid biosynthetic process;cholesterol catabolic process;digestion;sterol metabolic process;bile acid catabolic process;cholesterol homeostasis;oxidation-reduction process
- Cellular component
- endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- iron ion binding;steroid 7-alpha-hydroxylase activity;oxysterol 7-alpha-hydroxylase activity;heme binding